BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15125461)

  • 21. Protective effect of lafutidine, a histamine H2 receptor antagonist, against loxoprofen-induced small intestinal lesions in rats.
    Amagase K; Ochi A; Sugihara T; Kato S; Takeuchi K
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S111-8. PubMed ID: 20586851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intestinal protection by lafutidine, a histamine H(2)-receptor antagonist, against indomethacin-induced damage in rats--role of endogenous nitric oxide.
    Tanaka A; Mizoguchi H; Hase S; Miyazawa T; Takeuchi K
    Med Sci Monit; 2001; 7(5):869-77. PubMed ID: 11535926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The indomethacin-induced gastric mucosal damage in rats. Effect of gastric acid, acid inhibition, capsaicin-type agents and prostacyclin.
    Abdel Salam OM; Szolcsányi J; Mózsik G
    J Physiol Paris; 1997 Feb; 91(1):7-19. PubMed ID: 9210096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effect of lafutidine, a novel H2-receptor antagonist, on reflux esophagitis in rats through capsaicin-sensitive afferent neurons.
    Nagahama K; Yamato M; Kato S; Takeuchi K
    J Pharmacol Sci; 2003 Sep; 93(1):55-61. PubMed ID: 14501152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastroprotective mechanism of lafutidine, a novel anti-ulcer drug with histamine H2-receptor antagonistic activity.
    Onodera S; Shibata M; Tanaka M; Inaba N; Arai Y; Aoyama M; Lee B; Yamaura T
    Arzneimittelforschung; 1999 Jun; 49(6):519-26. PubMed ID: 10417869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of FRG-8813, a new histamine H2-receptor antagonist, on gastric mucus production in rats].
    Kagoshima M; Kodaira H; Tanaka M; Shimada H
    Nihon Yakurigaku Zasshi; 1995 Dec; 106(6):385-92. PubMed ID: 8582686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary agonists of TRPV1 inhibit gastric acid secretion in mice.
    Okumi H; Tashima K; Matsumoto K; Namiki T; Terasawa K; Horie S
    Planta Med; 2012 Nov; 78(17):1801-6. PubMed ID: 23047250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
    Sekiguchi H; Hamada K; Taga F; Nishino K
    Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of histamine H2-receptor antagonists and a proton pump inhibitor on the mucosal hydroxyproline content of ethanol-HCl-induced gastric lesions in rats.
    Suzuki T; Tsukamoto Y; Goto H; Hase S; Arisawa T; Asai J
    Digestion; 1992; 51(3):161-7. PubMed ID: 1387856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of a fluorescent imaging plate reader--based calcium assay to assess pharmacological differences between the human and rat vanilloid receptor.
    Witte DG; Cassar SC; Masters JN; Esbenshade T; Hancock AA
    J Biomol Screen; 2002 Oct; 7(5):466-75. PubMed ID: 14599363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of allyl isothiocyanate from horseradish on several experimental gastric lesions in rats.
    Matsuda H; Ochi M; Nagatomo A; Yoshikawa M
    Eur J Pharmacol; 2007 Apr; 561(1-3):172-81. PubMed ID: 17346695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effects of polygodial on gastric mucosal lesions induced by necrotizing agents in rats and the possible mechanisms of action.
    Pongpiriyadacha Y; Matsuda H; Morikawa T; Asao Y; Yoshikawa M
    Biol Pharm Bull; 2003 May; 26(5):651-7. PubMed ID: 12736506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of a combination of ecabet sodium and cimetidine on experimentally induced gastric lesions and gastric mucosal resistance to ulcerogenic agents in rats.
    Kinoshita M; Noto T; Tamaki H
    Biol Pharm Bull; 1995 Feb; 18(2):223-6. PubMed ID: 7742788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resiniferatoxin-type phorboid vanilloids display capsaicin-like selectivity at native vanilloid receptors on rat DRG neurons and at the cloned vanilloid receptor VR1.
    Szallasi A; Szabó T; Bíró T; Modarres S; Blumberg PM; Krause JE; Cortright DN; Appendino G
    Br J Pharmacol; 1999 Sep; 128(2):428-34. PubMed ID: 10510454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular pharmacological approach to drug actions on the afferent and efferent fibres of the vagal nerve involved in gastric mucosal protection in rats.
    Mózsik G; Dömötör A; Abdel-Salam OM
    Inflammopharmacology; 2006 Dec; 14(5-6):243-9. PubMed ID: 17139445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of 12-sulfodehydroabietic acid monosodium salt (TA-2711), a new anti-ulcer agent, on gastric mucosal lesions induced by necrotizing agents and gastric mucosal defensive factors in rats.
    Onoda Y; Takido M; Magaribuchi T; Tamaki H
    Jpn J Pharmacol; 1990 Apr; 52(4):631-8. PubMed ID: 2342230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The protective effects of rutaecarpine on gastric mucosa injury in rats.
    Wang L; Hu CP; Deng PY; Shen SS; Zhu HQ; Ding JS; Tan GS; Li YJ
    Planta Med; 2005 May; 71(5):416-9. PubMed ID: 15931578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Capsaicin-sensitive sensory neurons in healing gastric lesions induced by HCl in rats.
    Takeuchi K; Ohuchi T; Okabe S
    Dig Dis Sci; 1994 Dec; 39(12):2543-6. PubMed ID: 7995177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of FRG-8701 on gastric acid secretion, gastric mucosal lesions by necrotizing agents and experimental gastric or duodenal ulcer in rats.
    Shibata M; Yamaura T; Sekine A; Nishikawa M; Chida Y; Ohnishi H
    Jpn J Pharmacol; 1990 Nov; 54(3):277-85. PubMed ID: 1982548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gingerols: a novel class of vanilloid receptor (VR1) agonists.
    Dedov VN; Tran VH; Duke CC; Connor M; Christie MJ; Mandadi S; Roufogalis BD
    Br J Pharmacol; 2002 Nov; 137(6):793-8. PubMed ID: 12411409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.